Raltegravir and Atazanavir Dosing Strategy Study
Clinical trial NCT00874523 · COMPLETED
Trial details
- NCT number
- NCT00874523
- Sponsor
- Kirby Institute
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2011-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.